|
3-D Pharma
Acolyte Biomedica
Alfacell
Alita
Amarin
American Biogenetic Sciences
AndCare
Anergen
Atrix
Aurogen
Aventis
B. Braun
Baxter
Berkley Heart Labs
BioCancell
BioCryst
Biotrin
BMD
BMT
Brahms
Brenner Securities
Bristol-Myers Squibb
Carr Separations
Carter Wallace
Celgene
Cenix
Centeon
Chromagen
CLI Oncology
Closure Medical
Combinature
Connaught
Cytocell
Cytomyx
Daewoong
Devco
Discovery Labs
Drug Royalty
Dura
e2V Technologies
|
Emisphere
Enkam
Enzon
Federal Trade Commission (Trustee)
Focal, Inc.
Gamma-A
GEM Pharmaceuticals
Glyko
Gynetics
Haemacure
HCP
Hemispherx
Hycor
Immune Response Corp.
Immunomedics
IRM
Keystone Nano
KPL
La Jolla Pharmaceuticals
Lifecodes
Life Science Resources
Luminex
McKinley
MEC
MedCenter Inc
Medical Science Partners
Microprevention Tests
Mountain View Pharma
Natimmune
Neuromedica
Nitromed
Nitto Denko
NJ Economic Dev Auth
Nova Molecular
Noven
Odyssey Therapeutics
Omega
Optimata
Pennsylvania State Univ.
Pentech
Phairson, Ltd.
|
Pharmaply
Pheromone Sciences
Pipex
Pivotal
Proimmune
Prolong Pharmaceuticals
Response Biomedical
RGene Therapeutics
Rohm & Haas
Samyang
Scienion
Sense Proteomic
SK Corporation
Small Molecule Therapeutics
Societe General
Soros Fund Management
Southcoast Capital
Supratek
Surgicon
Tanabe Seiyaku
Tandem
Targeted Genetics
Teijin
TeraView
Teva
Thermo BioStar
Toolgen
Toray-Fuji Bionics
Transgenic Products
Transmolecular
Trinity Biotech
U.S. Biomaterials
Ultrafem
Univ. Cambridge/MIT
Veritas
Vestar
Visus
Watson Phamaceuticals
WelGene
Zeneca
Zeus
|